Ubs Asset Management Americas Inc Compugen LTD Transaction History

Ubs Asset Management Americas Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.57 - $3.33 $97,387 - $206,559	-62,030 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.09 - $7.16 $13,824 - $24,200	3,380 Added 5.76%	62,030 $266,000
Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $99,615 - $132,820	-14,500 Reduced 19.82%	58,650 $485,000
Q4 2020 Mar 01, 2021	SELL	$12.07 - $17.95 $39,831 - $59,235	-3,300 Reduced 4.32%	73,150 $885,000
Q3 2020 Nov 13, 2020	BUY	$14.16 - $19.45 $266,208 - $365,660	18,800 Added 32.61%	76,450 $1.24 Million
Q2 2020 Aug 14, 2020	BUY	$6.97 - $17.12 $401,820 - $986,968	57,650 New	57,650 $865,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $122M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.